NFKB1 and inflammatory bowel disease: In inflammatory bowel disease (IBD), pH/enzyme-responsive carriers localize drug delivery to gut lesions, while integrated NPs scavenge ROS, inhibit NF-κB, and reduce colitis relapse [195, 196].